These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 395452)

  • 21. [The behavior of blood insulin and glucose in diabetic nephropathy under CAPD].
    Thomae U; Kuhlmann H; Boos W; Herrmann M; Eberhard K
    Med Welt; 1980 Oct; 31(44):1599-601. PubMed ID: 7005589
    [No Abstract]   [Full Text] [Related]  

  • 22. Intraperitoneal insulin and the malignant omentum syndrome.
    Harrison NA; Rainford DJ
    Nephrol Dial Transplant; 1988; 3(1):103. PubMed ID: 3132630
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chronic peritoneal dialysis in treatment of irreversible chronic failure complicating diabetic nephropathy].
    Wańkowicz Z; Pietrzak B; Durlik M
    Pol Tyg Lek; 1993 May 17-31; 48(20-22):460-3. PubMed ID: 8170810
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term continuous ambulatory peritoneal dialysis in diabetics.
    Balaskas EV; Yuan ZY; Gupta A; Meema HE; Blair G; Bargman J; Oreopoulos DG
    Clin Nephrol; 1994 Jul; 42(1):54-62. PubMed ID: 7923968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous versus subcutaneous insulin in the postoperative juvenile-onset diabetes mellitus (JODM) patient receiving a renal cadaver transplant.
    Fisher PB; Bennett WM; Norman D; Barry JM
    Proc Clin Dial Transplant Forum; 1980; 10():258-9. PubMed ID: 7050987
    [No Abstract]   [Full Text] [Related]  

  • 26. Recommendations for glucose control in diabetics on CAPD.
    Passadakis P; Thodis E; Vargemezis V; Oreopoulos G
    Int J Artif Organs; 1999 Oct; 22(10):657-64. PubMed ID: 10585128
    [No Abstract]   [Full Text] [Related]  

  • 27. [Preparation for surgery of an insulin-dependent diabetic patient].
    Manunta A; Di Saverio G; Bergamaschi R; Enea D; Camilleri G; Giani L
    Minerva Chir; 1988 Sep; 43(17):1377-80. PubMed ID: 3062494
    [No Abstract]   [Full Text] [Related]  

  • 28. [References for a blood glucose lowering effect of tritoqualine in insulin treated diabetic patients].
    Köbberling J; Cüppers HJ; Hintze G; Richter K; Rommelmann F; Tillil H
    Med Klin (Munich); 1988 Sep; 83(18):596-600. PubMed ID: 3054462
    [No Abstract]   [Full Text] [Related]  

  • 29. Facilitating intensive conventional insulin management using a manually operated syringe injector.
    Updike SJ; Shults MC; Cornwell ST; Tuffli GA; Zografi GD
    Diabetes Res; 1984 Sep; 1(3):135-41. PubMed ID: 6529886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid restoration of normoglycaemia using intravenous insulin boluses.
    Dunnett JM; Steemson J; Sear JW; Turner RC; Holman RR
    Diabetes Res; 1990 Dec; 15(4):151-5. PubMed ID: 2132403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advantages of continuous ambulatory peritoneal dialysis to the diabetic with renal failure.
    Flynn CT; Hibbard J; Dohrman B
    Proc Eur Dial Transplant Assoc; 1979; 16():184-93. PubMed ID: 548979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The frequency of Th2 type cells increases with time on peritoneal dialysis in patients with diabetic nephropathy.
    Zamauskaite A; Yaqoob MM; Madrigal JA; Cohen SB
    Eur Cytokine Netw; 1999 Jun; 10(2):219-26. PubMed ID: 10400828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sulodexide in the treatment of right hand necrosis in diabetic patient performing exchanges of continuous ambulatory peritoneal dialysis (CAPD) by himself].
    Olszowska A; Pietrzak B; Wańkowicz Z
    Pol Merkur Lekarski; 1998 Nov; 5(29):301-3. PubMed ID: 10101507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New prospects for insulin therapy in type 1 diabetes].
    Brunetti P
    Recenti Prog Med; 1986 May; 77(5):241-4. PubMed ID: 3526460
    [No Abstract]   [Full Text] [Related]  

  • 35. [Diabetes mellitus and sports. Why the athletic diabetic patient uses less insulin].
    Neye H
    Med Monatsschr Pharm; 1994 Sep; 17(9):273-6. PubMed ID: 7968779
    [No Abstract]   [Full Text] [Related]  

  • 36. Initiation of dialysis in a patient with diabetes and chronic kidney disease.
    McFarland HF
    Nephrol Nurs J; 2005; 32(2):219-20. PubMed ID: 15889806
    [No Abstract]   [Full Text] [Related]  

  • 37. Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress.
    Cighetti G; Fermo I; Aman CS; Ferraroni M; Secchi A; Fiorina P; Paroni R
    Free Radic Biol Med; 2009 Aug; 47(3):307-11. PubMed ID: 19446631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The blood insulin equilibrium during periodic peritoneal dialysis in chronic renal insufficiency].
    Mirouze J; Mion C; Orsetti A; Jullien C
    J Urol Nephrol (Paris); 1967; 73(10):790-801. PubMed ID: 5596274
    [No Abstract]   [Full Text] [Related]  

  • 39. Intraperitoneal insulin for control of blood sugar in diabetic patients during peritoneal dialysis.
    Crossley K; Kjellstrand CM
    Br Med J; 1971 Jan; 1(5743):269-70. PubMed ID: 5100499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. President's message: Diabetes Control and Complications Trial (DCCT): implications for the ESRD population. Interview by Terran Warren Sims.
    Hunt CS
    ANNA J; 1994 Feb; 21(1):10-1. PubMed ID: 8141631
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.